Revenue: EUR17.4 billion, nearly at the same level as the prior year quarter. EBITDA Before Special Items: EUR2.6 billion, decreased by EUR87 million compared to Q1 2024. Adjusted EBITDA Margin Before Special Items: 6.5%, almost stable compared to the prior year quarter. EBIT Before Special Items: EUR1.7 billion, compared with EUR1.8 billion in the prior year quarter. Special Items in EBIT: Minus EUR467 million, mainly due to the sale of BASF's share in wind farms. Net Income: Decreased by EUR560 million to EUR808 million. Cash Flows from Operating Activities: Minus EUR982 million. Free Cash Flow: Minus EUR1.8 billion, compared with minus EUR1.5 billion in Q1 2024. Net Debt: Increased by EUR1.6 billion to EUR20.4 billion. Equity Ratio: 45.9%, unchanged and very healthy. Volume Decline in North America and US: 9% compared with the prior year quarter. Volume Increase in Asia Pacific: 2% and in Greater China by 7%. Volume Increase in Europe: 2%, while in Germany, they increased by 6%. Volume Increase in South America, Africa, and Middle East: 7% in Q1 2025.

Warning! GuruFocus has detected 6 Warning Signs with BASFY.

Release Date: May 02, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

BASF SE (BASFY) maintained its EBITDA before special items at about the same level as the prior year quarter, aligning with analyst estimates. The company has a strong manufacturing footprint with 90% of sales in Europe and North America coming from locally manufactured products, enhancing resilience. Sales volumes increased in Asia Pacific by 2% and in Greater China by 7%, indicating growth in these regions. BASF SE (BASFY) is investing in expanding production capacity for semiconductor-grade sulfuric acid, aligning with growing demand in Europe. The company maintains a strong balance sheet with a 45.9% equity ratio and a single A credit rating, ensuring favorable financing conditions.

Negative Points

BASF SE (BASFY) experienced a 9% volume decline in North America and the United States due to challenging market conditions. The Surface Technologies and Agricultural Solutions segments saw considerable volume declines, impacted by lower precious metals trading and presales in previous quarters. EBITDA before special items decreased by EUR87 million compared to the prior year, with several segments recording lower earnings. Cash flows from operating activities were negative, with a free cash flow of minus EUR1.8 billion, reflecting seasonal and operational challenges. The company faces uncertainty from US tariffs and potential counter tariffs, impacting customer sentiment and market dynamics.

Story Continues

Q & A Highlights

Q: Are you seeing any changes in terms of indirect consequences from tariff uncertainty in China or the US, and how confident are you in maintaining your full-year guidance given the current economic conditions? A: Dirk Elvermann, CFO, noted that while the direct impact of tariffs is limited, customer sentiment is cautious, leading to a softer start in the second quarter. The outlook remains unchanged, but there is more risk than before. The company will reassess after the second quarter to determine if guidance needs adjustment.

Q: Can you explain the EUR300 million loss on the wind farm investment and discuss the balance sheet's capacity for shareholder returns? A: Dirk Elvermann explained that the loss was due to converting a partnership into a PPA, avoiding future investments in a wind farm not needed until the 2030s. Christian Jutzi, President of Corporate Finance, emphasized BASF's strong equity ratio and credit rating, with plans to generate significant cash flow for future distributions.

Q: How are global economic conditions affecting the timing of potential disposals, and what levers do you have left to reduce spending if needed? A: Dirk Elvermann stated that the disposal process is on track despite challenging conditions. BASF is accelerating cost-saving efforts, aiming for an additional EUR100 million in savings by year-end, and is prepared to implement further measures if necessary.

Q: What is the current situation in China regarding demand and the impact on your Nutrition & Care business? A: Dirk Elvermann noted that China's demand is stable, with no further improvement or deterioration expected. Christian Jutzi added that Nutrition & Care is recovering from last year's incident, with production ramping up and expected positive results in the second half of the year.

Q: What are the expectations for the new China plant and the impact of tariffs on ramp-up costs? A: Dirk Elvermann confirmed that the China plant is on track for completion by year-end, with high utilization expected. Ramp-up costs are anticipated to remain as planned, with no current concerns about increased costs due to tariffs.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

View Comments